Timber Hill’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-11,100
Closed -$416K 2105
2016
Q4
$416K Sell
11,100
-1,000
-8% -$41.9K 0.04% 1739
2016
Q3
$820K Buy
12,100
+6,200
+105% +$437K 0.08% 1227
2016
Q2
$327K Sell
5,900
-23,600
-80% -$1.49M 0.03% 1773
2016
Q1
$1.85M Buy
29,500
+21,800
+283% +$1.45M 0.14% 959
2015
Q4
$725K Sell
7,700
-27,100
-78% -$2.51M 0.08% 1506
2015
Q3
$2.8M Buy
34,800
+25,700
+282% +$2.86M 0.29% 834
2015
Q2
$1.09M Buy
9,100
+7,100
+355% +$848K 0.08% 1453
2015
Q1
$209K Sell
2,000
-3,000
-60% -$304K 0.02% 2201
2014
Q4
$485K Buy
+5,000
New +$463K 0.03% 1885
2014
Q3
Sell
-7,600
Closed -$480K 2564
2014
Q2
$480K Sell
7,600
-11,500
-60% -$684K 0.05% 2131
2014
Q1
$1.28M Buy
+19,100
New +$1.48M 0.16% 1445
2013
Q3
Sell
-13,900
Closed -$431K 3192
2013
Q2
$431K Buy
+13,900
New +$370K 0.04% 2589

Other funds holding ALNY